LBT 5.56% 1.7¢ lbt innovations limited

Ann: US FDA 510k Submitted for APAS Independence, page-13

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 44 Posts.
    lightbulb Created with Sketch. 43

    3 point plan to increase the share price


    1.  Director's, start buying shares on market, (rather than during capital raises).  Show the share holders you are confident in the company especially at these prices  -  BUY more...  Look to Ellex lasers, (ELX) for an example of director's  purchasing shares on market or even RAP when they had negative news 12 months ago....  


    2. Negotiate or renegotiate with Sonic Health Care, Australia's largest pathology provider with a network of 12 pathology companies Australia wide.  (Clinpath, Southern IML pathology, Melbourne pathology and the like.)  Sonic also have a network of international laboratories in Germany, the USA, Switzerland, Belgium, the U.K, New Zealand.  They also do commercial testing of water and other agents which our APAS apparently can be adapted to test.    https://www.sonichealthcare.com/services/laboratory-medicine-pathology/australia/  (Well worth a look)  It would seem that Sonic are capable  of some very "heavy lifting"...


    3. Make those initial sales, apply for the CE mark, announce the distributor, deliver results.


    If this occurs then I predict a share price above 8.7 cents... 

     

      

 
watchlist Created with Sketch. Add LBT (ASX) to my watchlist
(20min delay)
Last
1.7¢
Change
-0.001(5.56%)
Mkt cap ! $23.13M
Open High Low Value Volume
1.8¢ 1.8¢ 1.7¢ $13.20K 747.0K

Buyers (Bids)

No. Vol. Price($)
4 776749 1.7¢
 

Sellers (Offers)

Price($) Vol. No.
1.8¢ 238095 1
View Market Depth
Last trade - 16.10pm 26/11/2024 (20 minute delay) ?
LBT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.